Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.3119
+0.0054 (1.76%)
Jun 23, 2025, 4:00 PM - Market closed
Rallybio Market Cap
Rallybio has a market cap or net worth of $12.98 million as of June 24, 2025. Its market cap has decreased by -79.67% in one year.
Market Cap
12.98M
Enterprise Value
-41.40M
1-Year Change
-79.67%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $12.98M, a decrease of -96.80%. That is a compound annual growth rate of -58.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 12.75M | -67.98% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |